Highlights Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Real-time Estimate Cboe BZX Other stock markets 16:59:05 08/05/2024 BST			5-day change	1st Jan Change
137.2 ^USD	+0.18%		-0.21%	-0.45%

05-06	Quest Diagnostics Appoints Murali Balakumar as Senior Vice President and Chief Information and Digital Officer	CI
05-01	Quest Diagnostics to Acquire PathAI Diagnostics Assets in Collaboration Deal	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Quest Diagnostics to Acquire PathAI Diagnostics Assets in Collaboration Deal	05-01	MT
Quest Diagnostics Forms Licensing Agreements with PathAI	05-01	CI
US FDA publishes final rule for laboratory developed tests	04-29	RE
Labcorp beats quarterly estimates on strong testing demand	04-25	RE
Quest Diagnostics Posts Flat Q1 Adjusted Earnings, Revenue Rises; 2024 Earnings, Revenue Guidance Raised	04-23	MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Reports Q1 Revenue $2.37B, vs. Street Est of $2.29B	04-23	MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Posts Q1 EPS $2.04, vs. Street Est of $1.86	04-23	MT
Quest Diagnostics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	04-23	CI
Quest Diagnostics Incorporated Updates Earnings Guidance for the Full Year of 2024	04-23	CI
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease	04-22	CI
Ex-dividend day	04-04	FA
Quest Collaborating With Broad Clinical Labs to Assess Whole Genome Sequencing Test for Developmental Delay Disorders	04-02	MT
Quest Diagnostics Incorporated acquired Assets of Lenco Diagnostic Laboratories, Inc. for approximately $110 million.	02-21	CI
Quest Diagnostics' Pack Health, Instacart to Combine Grocery Delivery With Nutrition Coaching Services	02-21	MT
Correction: Quest Diagnostics Participates in Freenome's $254 Million Financing	02-15	MT
Quest Diagnostics Participates in Freenome's $254 Million Financing	02-15	MT
Quest Diagnostics Incorporated Announces the Launch of MelaNodal Predict	02-13	CI
Quest Diagnostics Incorporated Announces the Availability of the First Consumer-Initiated, Physician-Ordered Blood-Draw Test for PFAS Chemicals	02-12	CI
Quest Diagnostics' Q4 Adjusted Earnings Increase, Revenue Declines; Issues 2024 Outlook; Raises Dividend	02-01	MT
(DGX) QUEST DIAGNOSTICS Sees Fiscal Year 2024 Revenue Range $9.35B - $9.45B	02-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Highlights

Filters